Motus GI Holdings, Inc.

MOTS Healthcare Medical Devices

Motus GI Holdings, Inc.’s revenue for fiscal 2023 (year ended December 2023) was $319,000.00, down 46.1% from fiscal 2022. Operating cash flow growth for three consecutive years.

0.00 0.00 NaN
Market cap
$420.0K
P/E
0.0×
Fwd P/E
0.0×
Dividend yield
—
F-score
2/9
Altman Z
−34.74
Beneish M
n/a
Dividend safety
n/a
Older periods Jun '23 Sep '23 Dec '23 Mar '24
Piotroski F-Score

+8 more TTM periods

3 2 2 3
ROE
(1,065.40%) 1,601.86% (454.34%) (1,624.82%)
ROA
(100.74%) (106.31%) (103.47%) (166.89%)
ROIC
(3,005.53%) (854.19%) (744,187.50%) (1,411.26%)
Return on Tangible Assets
(244.05%) (414.73%) (369.85%) (482.38%)
Average Days of Receivables
69.59 102.28 86.96 90.41
Free Cash Flow per Share
(30.34) (21.55) (13.95) (0.98)
Free Cash Flow
(15.29) (13.49) (11.30) (8.41)
Capital Expenditures
(0.26) (0.11) (0.10) —
Other line items
Cash ROIC
(88.04%) (108.49%) (113.93%) (81.60%)
Accounts Receivable Turnover
5.95 2.77 4.73 4.92
Accounts Payable Turnover
0.43 0.36 0.30 0.27
Inventory Turnover
1.06 1.06 1.55 1.18
Average Days of Payables
680.04 709.67 1,181.60 1,340.72
Days of Inventory on Hand
206.32 197.02 157.16 204.47
Tax Rate
0.00 0.00 0.00 0.00
Research and Development Expense of Revenue
923.74% 1,169.23% 1,086.83% 754.74%
Selling, General and Administrative Expense of Revenue
1,871.22% 2,421.98% 2,567.40% 2,148.62%
Share Based Compensation of Revenue
197.48% 206.04% 147.65% 97.86%
Interest Coverage
(7.54) (7.03) (15.65) (15.90)
Operating CF/Net income
0.94 0.97 0.87 0.52
Depreciation/Fixed assets
0.90 0.94 0.94 0.96
Capex/Depreciation
(0.24) (0.11) (0.11) 0.00
Revenue per Share
1.10 0.58 0.39 0.04
Operating CF per Share
(29.82) (21.37) (13.82) (0.98)
Capex per Share
(0.52) (0.18) (0.13) 0.00
Capex to Sales
0.47 0.31 0.33 0.00

Fold the line items

Columns are period end dates